First, while our study identified Igfbp2 as a key mediator in anesthesia‐induced cognitive impairment, the specific signaling pathways and molecular mechanisms through which Igfbp2 affected neuronal excitability and synaptic function warrant further research. The gene discussed is IGFBP2; the disease is Cognitive impairment.